Biotech Industry News

A collection of Biotech latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

businessinsider.com - Zachary Tracer - Salaries at top biotech, pharma companies: Endpoints News
Salaries at top biotech, pharma companies: Endpoints News
Insider

Workers at biotech and pharma companies can command big paychecks. Endpoints News compiled data from hundreds of companies to reveal their median salaries. Read on to see the companies that pay workers the most, with annual salaries above $400,000.

fool.com - Jim Halley - 2 Top Biotech Stocks to Buy in June
2 Top Biotech Stocks to Buy in June
The Motley Fool

Biotech stocks have taken investors on an unpredictable ride so far in 2023. One of the most popular biotech exchange-traded funds (ETFs), the iShares Biotechnology ETF, which focuses mostly on large-cap stocks, is down by about 1% year to date.

nzherald.co.nz - Jamie Gray - Fonterra spends US$10m on US biotech stake
Fonterra spends US$10m on US biotech stake
NZ Herald

Fonterra is dipping its toes into the biotech industry by taking a minority stake in US firm Pendulum. Photo / File Fonterra has set up a new corporate ventures arm to explore opportunities in nutrition science. The co-op said the new entity, which…

reuters.com - Julie Zhu - Chinese investors flock to Riyadh conference seeking new markets, capital
Chinese investors flock to Riyadh conference seeking new markets, capital
Reuters

HONG KONG/RIYADH, June 9 (Reuters) - Chinese entrepreneurs and investors are flocking to Riyadh this week to attend a business conference, which will bring together business and government leaders aiming to explore expansion and fundraising…

journalnow.com - RICHARD CRAVER Staff Reporter - NC A&T, Merck plans biotech training center
NC A&T, Merck plans biotech training center
Winston-Salem Journal

N.C. A&T State University and Merck announced Thursday they will collaborate on a biotechnology training center at Gateway Research Park's South Campus in east Greensboro. Merck will outfit the facility with the equipment and classroom spaces…

ft.com - Clive Cookson - UK cell therapy start-up agrees AstraZeneca partnership worth up to $2bn
UK cell therapy start-up agrees AstraZeneca partnership worth up to $2bn
Financial Times

Quell Therapeutics is developing cell engineering that aims to treat autoimmune diseases We'll send you a myFT Daily Digest email rounding up the latest Biotech news every morning. One of the most promising UK biotech start-ups, Quell Therapeutics…

wsj.com - Yuliya Chernova - More Startups Throw in the Towel, Unable to Raise Money for Their Ideas
More Startups Throw in the Towel, Unable to Raise Money for Their Ideas
Wall Street Journal

The pace of startup shutdowns, fire sales and sharp business-strategy changes is picking up. Fresh capital from venture investors and bank loans is scarce and expensive. Going public is near impossible. Some business models that worked when cash…

foodmanufacture.co.uk - JBS begins construction of world's largest cultivated beef protein plant
JBS begins construction of world's largest cultivated beef protein plant
foodmanufacture.co.uk

JBS has begun building the world's largest cultivated beef protein plant in San Sebastián, Spain. The first commercial scale industrial plant of BioTech Foods, of which JBS is the majority shareholder (53%), is expected to be completed next…

crunchbase.com - {'@id':'https:////news.crunchbase.com//#//schema//person//587df9e61346ee2cecd65c405991f9c7'} - The Week's 10 Biggest Funding Rounds: CleanCapital and Upstream Bio Lead Huge Week
The Week's 10 Biggest Funding Rounds: CleanCapital and Upstream Bio Lead Huge Week
Crunchbase

Want to keep track of the largest startup funding deals in 2023 with our new curated list of $100 million-plus venture deals to U.S.-based companies? Check out our new Megadeals Tracker here. This is a weekly feature that runs down the week's top…

phys.org - Nanoparticle therapy targeting specific immune cells appears promising for sepsis
Nanoparticle therapy targeting specific immune cells appears promising for sepsis
Phys.org

This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility: Nanoparticles consisting of a designer protein that counteract an…

statnews.com - {'@id':'https:////www.statnews.com//#//schema//person//5a990e144a5ebf7a9bef3a36e270ab01'} - Tracking the FDA advisory panel on Eisai and Biogen's treatment for Alzheimer's disease
Tracking the FDA advisory panel on Eisai and Biogen's treatment for Alzheimer's disease
STAT

Biotech Robert Weisman — Boston Globe The Food and Drug Administration is convening a meeting of outside experts on Friday to consider full approval for Leqembi, the Alzheimer's treatment made by Eisai and Biogen. Leqembi was granted…

statnews.com - {'@id':'https:////www.statnews.com//#//schema//person//e2a40ebcf735f7b69009aca6c7099e36'} - Updated data show long-term benefits of CRISPR treatment for sickle cell, beta thalassemia
Updated data show long-term benefits of CRISPR treatment for sickle cell, beta thalassemia
STAT

Biotech Robert Weisman — Boston Globe FRANKFURT — Updated results released Friday highlighted the lasting benefits of a CRISPR-based medicine for blood disorders developed by Vertex Pharmaceuticals and CRISPR Therapeutics, as the…

investors.com - JUSTIN NIELSEN - 4 Growth Stocks In Health Care Near Breakouts. But Watch These Flaws.
4 Growth Stocks In Health Care Near Breakouts. But Watch These Flaws.
Investor's Business Daily

Several health care stocks in the IBD 50 are forming bases, in what could be another emerging wave of leadership. Shockwave Medical () is approaching a buy point of 308.09 in a cup-with-handle base. The base and handle are deeper than normal, which…

statnews.com - {'@id':'https:////www.statnews.com//#//schema//person//e171cd0e70a851d1e0fe107a911511aa'} - Drug companies and pharmacies reach $17.3 billion settlement over opioid crisis
Drug companies and pharmacies reach $17.3 billion settlement over opioid crisis
STAT

Biotech Robert Weisman — Boston Globe Two large drugmakers and two of the biggest pharmacy chains finalized a $17.3 billion deal to settle accusations by state governments that they contributed to the opioid crisis that swept across the U.S.

pbn.com - {'@id':'https:////pbn.com//#//schema//person//f2c204a8af2fa3703dc6b5396011abde'} - Can biotech hubs coexist?
Can biotech hubs coexist?
Providence Business News

While Boston has long stood as a regional and ­national life sciences capital, Rhode Island officials and industry leaders believe the Ocean State has what it needs to hold its own against the neighboring biotech giant. But first, they say, the…

Receive a Daily briefing on Biotech Industry News

Get Started